IMCD reports EBITA of EUR 403 million in the first nine months of 2024
08 November 2024 - 5:00PM
UK Regulatory
IMCD reports EBITA of EUR 403 million in the first nine months of
2024
Rotterdam, The Netherlands (8 November 2024) -
IMCD N.V. (“IMCD” or “Company”), a global leading distribution
partner, and formulator of speciality chemicals and ingredients,
today announces its first nine months 2024 results.
HIGHLIGHTS
• Gross profit increase of 6% to EUR 909 million (+8% on a constant
currency basis)
• Operating EBITA increase of 1% to EUR 403 million (+3% on a
constant currency basis)
• Free cash flow of EUR 299 million (first nine months of 2023: EUR
364 million)
• Cash earnings of EUR 4.67 (first nine months of 2023: EUR
4.68)
• Strengthening of our position in all operating segments through
12 acquisitions year to date
Valerie Diele-Braun, CEO: "I am pleased to report solid results for
the first nine months of the year, despite the volatile global
economic environment. On a forex adjusted basis, we delivered gross
profit growth of 8% and an increase in operating EBITA of 3%. All
segments contributed to our organic operating EBITA growth of 5% in
the third quarter. Furthermore, we successfully expanded our global
network and product portfolio by three acquisitions in EMEA
and Latin America. We continue to look for opportunities to
further strengthen our business through expansion of our product
portfolio and by selective acquisitions, whilst remaining focused
on optimising our commercial and operational excellence."
Attached, the full press release in PDF format.
- PR_IMCD first nine months of 2024 results
IMCD NV (EU:IMCD)
Historical Stock Chart
From Oct 2024 to Nov 2024
IMCD NV (EU:IMCD)
Historical Stock Chart
From Nov 2023 to Nov 2024